Drug Profile
Research programme: meningococcal vaccine - Sinovac
Alternative Names: Meningitis vaccine - SinovacLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Sinovac Biotech
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Meningococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Meningococcal-infections in China (Parenteral)